Welcome to our dedicated page for Rocket Doctor AI news (Ticker: AIRDF), a resource for investors and traders seeking the latest updates and insights on Rocket Doctor AI stock.
Rocket Doctor AI Inc. reports developments tied to its physician-led, AI-powered healthcare technology business and its wholly owned Rocket Doctor Inc. digital health platform and marketplace. Company news commonly covers U.S. payer network agreements, state-by-state access expansion, physician services delivered through the platform, and updates to primary care, chronic disease management, preventive care, virtual urgent care, and specialist coordination.
Recurring announcements also address financial results, product and engineering capacity, equity-based compensation, clinical AI initiatives, and the Global Library of Medicine decision support system. The company’s completed acquisition of Alea Health Holdings Ltd. adds conversational AI-powered mental health capabilities to its healthcare technology profile.
Rocket Doctor AI (OTC:AIRDF) announced engagement of Fundamental Research Corp for independent analyst coverage effective Oct 21, 2025.
FRC is described as a long‑standing independent small‑cap research firm with a 22‑year track record and coverage of 750+ companies; its reports are distributed via Reuters, Capital IQ, Bloomberg and by subscription.
Under the agreement FRC will deliver a full financial analysis including an Independent Analyst Rating, an initiating report, periodic updates and unlimited interim notes over an 18‑month term. The company paid FRC a fee of CAD$35,000 in connection with the engagement.
Rocket Doctor (OTC:AIRDF) announced on October 21, 2025 that its Rocket Doctor platform is now in-network with two additional U.S. payers, expanding coverage by approximately 6.5 million members across California and New York.
The agreements (signed on October 9 and 10, 2025) add ~2.7 million covered lives in California and ~3.8 million in New York, bringing Rocket Doctor’s total in-network reach to well over 13 million members. The contracts span commercial, Medicare Advantage, and Veterans coverage and aim to broaden access to AI-powered, physician-led primary, urgent, chronic and mental healthcare.
Rocket Doctor AI (OTC:AIRDF) engaged FN Media Group for a three-day news and digital media marketing campaign starting the week of October 20, 2025 for USD $14,085.
FN Media will use its proprietary traffic application plus Google/Yahoo digital ads. The firm and its directors do not own any interest in Rocket Doctor AI and are described as arm’s length. FN Media contact details and address are provided in the announcement.
Rocket Doctor AI (OTC: AIRDF) announced that its U.S. subsidiary Treatment.com, together with Rush River Research, received a US $2.0 million NIH SBIR Phase II grant awarded by the National Institute on Minority Health and Health Disparities.
The two-year award advances an AI-powered, culturally sensitive family medical history tool, provides Treatment with over $500,000 to enhance its Global Library of Medicine (GLM), and supports commercialization and integration across commercial platforms with usability and community testing focused initially on African-American communities.
Rocket Doctor AI (OTCQB: AIRDF), a healthcare technology company, will present at the 2025 CANTech Letter Conference in Toronto on October 9, 2025. CEO Dr. Essam Hamza and Rocket Doctor Inc. Founder Dr. William Cherniak will deliver their presentation at 2:30 PM ET in Track 1.
The presentation will showcase the company's AI-powered healthcare platform, which focuses on improving healthcare accessibility and patient outcomes through streamlined workflows and reduced administrative friction. The company's leadership will discuss their platform innovations, recent milestones, and growth strategy.